Stephen C. Glover
2022
In 2022, Stephen C. Glover earned a total compensation of $1.5M as Co-Founder, Chief Executive Officer President and Chairman at ZyVersa Therapeutics.
Compensation breakdown
| Option Awards | $1,027,948 |
|---|---|
| Salary | $450,500 |
| Total | $1,478,448 |
Glover received $1M in option awards, accounting for 70% of the total pay in 2022.
Glover also received $450.5K in salary.
Rankings
In 2022, Stephen C. Glover's compensation ranked 2,252nd out of 5,753 executives tracked by ExecPay. In other words, Glover earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,252 out of 5,753 | 61st |
Division Manufacturing | 1,222 out of 3,133 | 61st |
Major group Chemicals And Allied Products | 538 out of 1,419 | 62nd |
Industry group Drugs | 494 out of 1,320 | 63rd |
Industry Pharmaceutical Preparations | 359 out of 966 | 63rd |
Source: SEC filing on September 9, 2024.
Glover's colleagues
We found two more compensation records of executives who worked with Stephen C. Glover at ZyVersa Therapeutics in 2022.